l carnitine atherosclerosis Carnitine, Choline, Cancer, & Cholesterol: The TMAO Connection γ–Butyrobetaine is a pro-atherogenic intermediate
Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans Frontiers Acetyl L carnitine ameliorates atherosclerosis in LDLR mice by modulating cholesterol metabolism through SREBP2 dependent cholesterol biosynthesis Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect
Pay in 4 interest-free payments of $5.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



